|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
EBSCO_ocn880827447 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
140531s2014 enk ob 001 0 eng d |
010 |
|
|
|a 2013042467
|
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d IDEBK
|d N$T
|d OCLCQ
|d MOR
|d YDX
|d OCLCO
|d MERUC
|d OCLCO
|d OCLCQ
|d SAV
|d OCLCO
|d UAB
|d OCLCA
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d AGLDB
|d OCLCO
|d OCL
|d G3B
|d IGB
|d STF
|d AUW
|d BTN
|d INTCL
|d MHW
|d SNK
|d VT2
|d USU
|d E7B
|d OCLCF
|d YDXCP
|d S4S
|d S8I
|d OCLCA
|d OCLCQ
|d OCLCA
|d SFB
|d OCLCO
|d OCL
|d OCLCQ
|d INARC
|d OCLCO
|
019 |
|
|
|a 882262721
|a 883365562
|a 1058899273
|a 1103259257
|a 1228606090
|a 1298420634
|
020 |
|
|
|a 9780190200657
|q (electronic bk.)
|
020 |
|
|
|a 0190200650
|q (electronic bk.)
|
020 |
|
|
|a 9780199974580
|q (hbk. ;
|q alk. paper)
|
020 |
|
|
|a 0199974586
|
020 |
|
|
|a 9780197563335
|q (electronic bk.)
|
020 |
|
|
|a 0197563333
|q (electronic bk.)
|
029 |
1 |
|
|a AU@
|b 000055980480
|
029 |
1 |
|
|a DEBBG
|b BV042796508
|
029 |
1 |
|
|a AU@
|b 000069137020
|
035 |
|
|
|a (OCoLC)880827447
|z (OCoLC)882262721
|z (OCoLC)883365562
|z (OCoLC)1058899273
|z (OCoLC)1103259257
|z (OCoLC)1228606090
|z (OCoLC)1298420634
|
050 |
|
4 |
|a RM301.27
|
060 |
|
4 |
|a QV 771
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.1901
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Tansey, Michael,
|e author.
|
245 |
1 |
0 |
|a Intelligent drug development :
|b trials and errors in clinical research /
|c Michael Tansey.
|
264 |
|
1 |
|a Oxford ;
|a New York :
|b Oxford University Press,
|c [2014]
|
300 |
|
|
|a 1 online resource (241 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references (pages 213-215) and index.
|
505 |
0 |
|
|a Aiming for excellence -- The target product profile and its uses -- Planning the individual clinical trial -- Distilling the essence of the protocol: the protocol synopsis -- Redistillation: eliminating impurities by carrying out protocol feasibility -- The optimal blend: the approved synopsis and the final protocol -- Of chickens and eggs: the sponsors' dilemma -- Clinician or clinical trialist: the physicians' dilemma -- What about the customer? the patients' dilemma -- About time: making meetings matter -- The brain-scrambling, fit-inducing, mind-numbing technicolor laser show.
|
520 |
|
|
|a Clinical research is heavily regulated and involves coordination of numerous pharmaceutical-related disciplines. Each individual trial involves contractual, regulatory, and ethics approval at each site and in each country. Clinical trials have become so complex and government requirements so stringent that researchers often approach trials too cautiously, convinced that the process is bound to be insurmountably complicated and riddled with roadblocks. A step back is needed, an objective examination of the drug development process as a whole, and recommendations made for streamlining the proces.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Drugs
|x Testing
|x Methodology.
|
650 |
|
0 |
|a Drug development
|x Management.
|
650 |
|
0 |
|a Clinical trials
|x Ethics.
|
650 |
|
0 |
|a Clinical trials
|x Methods.
|
650 |
|
0 |
|a Drug approval
|x Methods.
|
650 |
|
0 |
|a Medical protocols.
|
650 |
1 |
2 |
|a Drug Approval
|x methods
|
650 |
2 |
2 |
|a Clinical Protocols
|
650 |
2 |
2 |
|a Clinical Trials as Topic
|x ethics
|
650 |
2 |
2 |
|a Clinical Trials as Topic
|x methods
|
650 |
|
6 |
|a Médicaments
|x Essais cliniques
|x Méthodologie.
|
650 |
|
6 |
|a Médicaments
|x Développement
|x Gestion.
|
650 |
|
6 |
|a Études cliniques
|x Morale.
|
650 |
|
6 |
|a Protocoles médicaux.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drugs
|x Testing
|x Methodology
|2 fast
|
650 |
|
7 |
|a Medical protocols
|2 fast
|
650 |
|
7 |
|a Clinical trials
|2 fast
|
650 |
|
7 |
|a Drug approval
|2 fast
|
655 |
|
7 |
|a Methods (Music)
|2 fast
|
776 |
0 |
8 |
|i Print version:
|a Tansey, Michael.
|t Intelligent Drug Development.
|d Oxford : Oxford University Press, 2014
|z 9780199974580
|w (DLC) 2013042467
|w (OCoLC)861895187
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=783528
|z Texto completo
|
938 |
|
|
|a Internet Archive
|b INAR
|n intelligentdrugd0000tans
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 16980884
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL1696428
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10875354
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 783528
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis28430886
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 11829587
|
994 |
|
|
|a 92
|b IZTAP
|